Abstract
Background
Breast adenocarcinoma cells (MCF-7) are characterized by the overexpression of apoptotic marker genes and proliferative cell nuclear antigen (PCNA), which promote cancer cell proliferation. Thymol, derived from Nigella sativa (NS), has been investigated for its potential anti-proliferative and anticancer properties, especially its ability to suppress Cyclin D1 and PCNA expression, which are crucial in the proliferation of cancer cells.
Methods
The cytotoxicity of thymol on MCF-7 cells was assessed using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) and lactate dehydrogenase (LDH) release methods. Thymol was tested at increasing concentrations (0–1000 µM) to evaluate its impact on MCF-7 cell growth. Additionally, Cyclin D1 and PCNA gene expression in thymol-treated and vehicle control groups of MCF-7 were quantified using real-time Polymerase Chain Reaction (RT-qPCR). Protein-ligand interactions were also investigated using the CB-Dock2 server.
Results
Thymol significantly inhibited MCF-7 cell growth, with a 50% inhibition observed at 200 µM. The gene expression of Cyclin D1 and PCNA was down-regulated in the thymol-treated group relative to the vehicle control. The experimental results were verified through protein–ligand interaction investigations.
Conclusions
Thymol, extracted from NS, demonstrated specific cytotoxic effects on MCF-7 cells by suppressing the expression of Cyclin D1 and PCNA, suggesting its potential as an effective drug for MCF-7. However, additional in vivo research is required to ascertain its efficacy and safety in medical applications.
Similar content being viewed by others
Data availability
All data displayed in this publication are available from the corresponding author upon request.
References
Karnik AA, Benjamin EJ, Trinquart L (2019) Breast cancer and atrial fibrillation—a malignant combination? Heart Rhythm 16:349
Rajaram N, Lim ZY, Song CV et al (2019) Patient-reported outcome measures among breast cancer survivors: a cross‐sectional comparison between Malaysia and high‐income countries. Psychooncology 28:147–153
Liaw YY, Loong FS, Tan S et al (2020) A retrospective study on breast cancer presentation, risk factors, and protective factors in patients with a positive family history of breast cancer. Breast J 26:469–473
Sung H, Rosenberg PS, Yang XR (2020) Re: contrasting epidemiology and clinicopathology of female breast cancer in Asians vs the US population. JNCI: J National Cancer Inst 112:545–546
Zamrus SNH, Akhtar MN, Yeap SK et al (2018) Design, synthesis and cytotoxic effects of curcuminoids on HeLa, K562, MCF-7 and MDA-MB-231 cancer cell lines. Chem Cent J 12:1–10
Dieterich M, Stubert J, Reimer T et al (2014) Influence of lifestyle factors on breast cancer risk. Breast Care 9:407–414
Rashid OM, Takabe K (2014) Does removal of the primary tumor in metastatic breast cancer improve survival? J Womens Health 23:184–188
Chen MCW, Gupta M, Cheung KC (2010) Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening. Biomed Microdevices 12:647–654
Zhao W, Wang H, Liu J et al (2018) Positive PCNA and Ki-67 expression in the testis correlates with spermatogenesis dysfunction in fluoride-treated rats. Biol Trace Elem Res 186:489–497
Holmes MJ, Brust A, Lewis RJ (2014) Dinoflagellate toxins: an overview. Seaf Freshw Toxins: Pharmacol Physiol Detect 3:3–38
Zhang J, Su G, Lin Y et al (2019) Targeting cyclin-dependent kinases in gastrointestinal cancer therapy. Discov Med 27:27–36
Li Z, Wang C, Prendergast G, Pestell RG (2006) Cyclin D1 functions in cell migration. Cell Cycle 5:2440–2442
Li Y, Liu J, Liu X et al (2006) Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9. Appl Biochem Biotechnol 135:181–192
Sun Y, Luo D, Liao DJ (2012) CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells. J Carcinog. https://doi.org/10.4103/1477-3163.100401
Das S, Ghosh A, Upadhyay P et al (2023) A mechanistic insight into the potential anti-cancerous property of Nigella sativa on breast cancer through micro-RNA regulation: an in vitro & in vivo study. Fitoterapia 169:105601
Ansary J, Giampieri F, Forbes-Hernandez TY et al (2021) Nutritional value and preventive role of Nigella sativa L. and its main component thymoquinone in cancer: an evidenced-based review of preclinical and clinical studies. Molecules 26:2108. https://doi.org/10.3390/molecules26082108
Poulose AJ, Croteau R (1978) Biosynthesis of aromatic monoterpenes: conversion of γ-terpinene to p-cymene and thymol in Thymus vulgaris L. Arch Biochem Biophys 187:307–314
Subratti A, Lalgee LJ, Jalsa NK (2019) Efficient extraction of black cumin (Nigella sativa L.) seed oil containing thymol, using liquefied dimethyl ether (DME). J Food Process Preserv 43:e13913
Aziz SA, Kurniawati A, Faridah DN (2017) Changes of thymoquinone, thymol, and malondialdehyde content of black cumin (Nigellasativa L.) in response to Indonesia tropical altitude variation. Hayati 24:156–161
Al-Jassir MS (1992) Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem 45:239–242
Al-Naqeep GN, Ismail MM, Al-Zubairi AS, Esa NM (2009) Nutrients composition and minerals content of three different samples of Nigellasativa L. cultivated in Yemen. Asian J Biol Sci 2:43–48
Al-Saleh IA, Billedo G, El-Doush II (2006) Levels of selenium, dl-α-tocopherol, dl-γ-tocopherol, all-trans-retinol, thymoquinone and thymol in different brands of Nigella sativa seeds. J Food Compos Anal 19:167–175
Behdarvand Shoushtar A, Sazegar H, Ghasemi Pirbaloti A (2017) Cytotoxic effect of hydroalcoholic extract from Satureja bachtiarica Bunge on HeLa cancer cells line. J Med Herbs 7:223–229
Mastelic J, Jerkovic I, Blažević I et al (2008) Comparative study on the antioxidant and biological activities of carvacrol, thymol, and eugenol derivatives. J Agric Food Chem 56:3989–3996
Deb DD, Parimala G, Devi SS, Chakraborty T (2011) Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem Biol Interact 193:97–106
Koosehgol S, Ebrahimian-Hosseinabadi M, Alizadeh M, Zamanian A (2017) Preparation and characterization of in situ chitosan/polyethylene glycol fumarate/thymol hydrogel as an effective wound dressing. Mater Sci Eng: C 79:66–75
Sirpu Natesh N, Arumugam M, Karanam G (2018) Apoptotic role of marine sponge symbiont Bacillus subtilis NMK17 through the activation of caspase-3 in human breast cancer cell line. Mol Biol Rep 45:2641–2651
Liu Y, Yang X, Gan J et al (2022) CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res 50:W159–W164
Yang X, Liu Y, Gan J et al (2022) FitDock: protein–ligand docking by template fitting. Brief Bioinform. https://doi.org/10.1093/bib/bbac087
Cortesina G, Martone T (2006) Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature. Acta Otorhinolaryngol Ital 26:317
Priestley CM, Williamson EM, Wafford KA, Sattelle DB (2003) Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABAA receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster. Br J Pharmacol 140:1363–1372
Itani WS, El-Banna SH, Hassan SB et al (2008) Anti colon cancer components from Lebanese sage (Salvia libanotica) essential oil: mechanistic basis. Cancer Biol Ther 7:1765–1773
Kang S-H, Kim Y-S, Kim E-K et al (2016) Anticancer effect of thymol on AGS human gastric carcinoma cells. J Microbiol Biotechnol 26:28–37
Sobral MV, Xavier AL, Lima TC, de Sousa DP (2014) Antitumor activity of monoterpenes found in essential oils. Sci World J. https://doi.org/10.1155/2014/953451
Lampronti I, Saab AM, Gambari R (2006) Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. Int J Oncol 29:989–995
Hassan SB, Gali-Muhtasib H, Göransson H, Larsson R (2010) Alpha terpineol: a potential anticancer agent which acts through suppressing NF-κB signalling. Anticancer Res 30:1911–1919
Stammati A, Bonsi P, Zucco F et al (1999) Toxicity of selected plant volatiles in microbial and mammalian short-term assays. Food Chem Toxicol 37:813–823
Altintas F, Tunc-Ata M, Secme M, Kucukatay V (2023) The anticancer effects of thymol on HepG2 cell line. Med Oncol 40:260
Weinstein IB (2000) Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 21:857–864
Hitomi M, Stacey DW (1999) Cyclin D1 production in cycling cells depends on Ras in a cell-cycle-specific manner. Curr Biol 9:1075–1084
Lung J, Chu J, Yu J et al (2002) Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes Chromosomes Cancer 34:276–284
Masilamani V, Al-Zhrani K, Al-Salhi M et al (2004) Cancer diagnosis by autofluorescence of blood components. J Lumin 109:143–154
Inwald EC, Klinkhammer-Schalke M, Hofstädter F et al (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139:539–552
Jamali T, Kavoosi G, Safavi M, Ardestani SK (2018) In-vitro evaluation of apoptotic effect of OEO and thymol in 2D and 3D cell cultures and the study of their interaction mode with DNA. Sci Rep 8:15787
Karim S, Al-Maghrabi JA, Farsi HMA et al (2016) Cyclin D1 as a therapeutic target of renal cell carcinoma-a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia. BMC Cancer 16:9–21
Elshal M, Eid N, El-Sayed I et al (2021) Concanavalin-a shows synergistic cytotoxicity with tamoxifen via inducing apoptosis in estrogen receptor-positive breast cancer: in vitro and molecular docking studies. Pharm Sci 28:76–85
Sofi S, Mehraj U, Qayoom H et al (2022) Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors. Med Oncol 39:133
Smith SJ, Gu L, Phipps EA et al (2015) A peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer. Mol Pharmacol 87:263–276
Peterson LE (2019) Small molecule docking of DNA repair proteins associated with cancer survival following PCNA metagene adjustment: a potential novel class of repair inhibitors. Molecules 24:645
Osmaniye D, Karaca Ş, Kurban B et al (2022) Design, synthesis, molecular docking and molecular dynamics studies of novel triazolothiadiazine derivatives containing furan or thiophene rings as anticancer agents. Bioorg Chem 122:105709
Acknowledgements
The authors extend their appreciation to the Researchers Supporting Project Number (RSPD2024R723), King Saud University, Riyadh, Saudi Arabia.
Funding
This work was supported by King Saud University (Grant No. RSPD2024R723)
Author information
Authors and Affiliations
Contributions
Conceptualization—VV, and GL; methodology—VV, PK; data curation—VV, GK, writing—original draft—GL; software—SP, GK, and PK; formal analysis—PK, and SP; writing—review and editing—SP, PK, GK, funding acquisition—MSA; project administration—MSA. All the authors read the final version of the manuscript and agreed to publish it.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethical approval
The author(s) of this article declare that the materials and methods used in this study do not require ethical committee permission and/or legal-special permission.
Consent to participant
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher’s Note
Springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vahitha, V., Lali, G., Prasad, S. et al. Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions. Mol Biol Rep 51, 61 (2024). https://doi.org/10.1007/s11033-023-09032-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11033-023-09032-w